The 2011 Top Ten World’s Leading Pharmaceutical Companies
US$ 10,560.00
... To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading pharmaceutical companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis ...
October 2010
1200 pages
The 2011 Leading Pharmaceutical Companies Strategic Directions
US$ 1,480.00
... product development, and marketing objectives and strategies. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
45 pages
The 2011 Leading Pharmaceutical Companies Financial Analyses
US$ 1,480.00
... , geographic region, therapeutic category, and individual drug. Five-year sales and operating profit performance. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ...
October 2010
130 pages
The 2011 Leading Pharmaceutical Companies Collaborative Arrangements
US$ 1,480.00
... , and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
200 pages
The 2011 Leading Pharmaceutical Companies Technological Know-How
US$ 1,480.00
... capabilities. Know-how in biotechnology and other pertinent fields. Proprietary technologies and patent litigations. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
50 pages
The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses
US$ 1,480.00
... review of major ethical, OTC, and generic drugs. Most recent new drug introductions and indications. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - ...
October 2010
275 pages
The 2011 Leading Pharmaceutical Companies Marketing Tactics
US$ 1,480.00
... force in the U.S., Europe, Asia, and other geographic regions. Distribution strategies. Major promotional tactics. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ...
October 2010
60 pages
The 2011 Leading Pharmaceutical Companies Comparative Analysis
US$ 680.00
Global PDF: US$ 1,900.00 This report ranks the world’s major pharmaceutical companies according to the following criteria: Sales and market shares. Operating profit and margins. R&D expenditures and percent of sales. The companies analyzed in the report: - AstraZeneca - Bristol- ...
October 2010
-
The 2011 Top 10 World’s Leading Semiconductor Companies
US$ 10,160.00
... : To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading semiconductor companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis ...
October 2010
650 pages
The 2011 Global Semiconductor Market Dynamics and Trends
US$ 1,480.00
Global PDF: US$ 3,900.00 A worldwide strategic overview of the semiconductor market, including: Sales forecasts for key geographic regions: Asia/Pacific, Japan, Americas, Europe. Sales forecasts for major product categories: ICS, Discrete, Optoelectronic, others. In addition, the report reviews the ...
October 2010
-
The 2011 Leading Semiconductor Companies Strategic Directions
US$ 1,480.00
... product development, and marketing objectives and strategies. Major strengths and weaknesses. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. ...
October 2010
45 pages
The 2011 Leading Semiconductor Companies Marketing Tactics
US$ 1,480.00
... For each company, the analysis presents: Sales force in the U.S. and other international markets. Distribution strategies. Promotional tactics. The companies analyzed in this report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. ...
October 2010
32 pages
The 2011 Leading Semiconductor Companies Comparative Analysis
US$ 680.00
Global PDF: US$ 1,900.00 This report compares the world’s major semiconductor companies according to the following criteria: Worldwide sales and rank. Sales by geographic region. Operating profit and margins. R&D expenditures and percent of sales. The companies analyzed in this report: Freescale, ...
October 2010
5 pages
The 2011 Leading Semiconductor Companies Collaborative Arrangements
US$ 1,480.00
... ventures, product development and marketing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. ...
October 2010
61 pages
The 2011 Leading Semiconductor Companies Financial Analyses
US$ 1,480.00
... Sales and operating profit by division, geographic region, market segment and product line. Five-year sales and operating profit performance. The companies analyzed in the report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. Contains 77 ...
October 2010
77 pages
The 2011 Leading Semiconductor Companies R&D Expenditures and Major Programs
US$ 1,480.00
... each company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and line extensions in development. The companies analyzed in the report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. ...
October 2010
36 pages
The 2011 Leading Semiconductor Companies Product Portfolio Analyses
US$ 1,480.00
... US$ 3,900.00 For each company, the analyses present: Review of major product lines. Recent product introductions and line extensions. The companies analyzed in this report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. Contains 130 ...
October 2010
130 pages
The 2011 Clinical Chemistry And Immunodiagnostics Markets: US, Europe, Japan
US$ 23,520.00
The 2011 Clinical Chemistry And Immunodiagnostics Markets: US, Europe, Japan - Product Development Opportunities And Business Expansion Strategies For Instrument And Reagent Suppliers During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The ...
June 2010
1115 pages
The 2011 Leading Orthopedics Companies R&D Expenditures and Major Programs
US$ 1,480.00
... 3,900.00 Each company's analysis provides: R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 30 ...
May 2010
30 pages
The 2011 Leading Orthopedics Companies Facilities and Employees
US$ 1,480.00
... R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. U.S. and international workforce size and distribution. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 40 ...
May 2010
40 pages
